Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Viens

Showing results (161-170 of 244) with videos related to

Pageof 25
Sort By:
European Journal of Cancer Care|August 28, 2009
Resection of residual masses after chemotherapy for advanced non-seminomatous germ cell tumours, a monocentric analysis of pre-operative prognosticatorsJ-L Deville, G Gravis, N Salem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2009
Cost-effectiveness of adjuvant docetaxel for node-positive breast cancer patients: results of the PACS 01 economic studyP Marino, C Siani, H Roché, et al.
Bone Marrow Transplantation|April 1, 1990
High dose melphalan and autologous marrow rescue in advanced epithelial ovarian carcinomas: a retrospective analysis of 35 patients treated in FranceP Viens, D Maraninchi, M Legros, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2000
Local and distant failures after limited surgery with positive margins and radiotherapy for node-negative breast cancerD Cowen, G Houvenaeghel, V Bardou, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1992
Interleukin-2 in association with increasing doses of interferon-gamma in patients with advanced cancerP Viens, D Blaise, A M Stoppa, et al.
Pathologie-Biologie|September 1, 1988
[Prophylaxis of Gram-positive infections after bone marrow graft. Controlled study of the 6-day administration of vancomycin. Intermediate analysis of 60 patients]D Maraninchi, O Hartman, E Benhamou, et al.
Bone Marrow Transplantation|August 1, 1991
Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patientsD Blaise, D Olive, M Hirn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
Patient participation in medical decision-making: a French study in adjuvant radio-chemotherapy for early breast cancerC Protière, P Viens, D Genre, et al.
Bone Marrow Transplantation|November 1, 1994
Delayed administration of granulocyte colony-stimulating factor after autologous bone marrow transplantation: effect on granulocyte recoveryN Vey, S Molnar, C Faucher, et al.
Acta Endocrinologica|July 1, 1993
Incidence rate and risk factors for thyroid dysfunction during recombinant interleukin-2 therapy in advanced malignanciesB Vialettes, M A Guillerand, P Viens, et al.
Pageof 25

Showing results (161-170 of 244) with videos related to

Sort By:
Pageof 25
European Journal of Cancer Care|August 28, 2009
Resection of residual masses after chemotherapy for advanced non-seminomatous germ cell tumours, a monocentric analysis of pre-operative prognosticatorsJ-L Deville, G Gravis, N Salem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2009
Cost-effectiveness of adjuvant docetaxel for node-positive breast cancer patients: results of the PACS 01 economic studyP Marino, C Siani, H Roché, et al.
Bone Marrow Transplantation|April 1, 1990
High dose melphalan and autologous marrow rescue in advanced epithelial ovarian carcinomas: a retrospective analysis of 35 patients treated in FranceP Viens, D Maraninchi, M Legros, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2000
Local and distant failures after limited surgery with positive margins and radiotherapy for node-negative breast cancerD Cowen, G Houvenaeghel, V Bardou, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1992
Interleukin-2 in association with increasing doses of interferon-gamma in patients with advanced cancerP Viens, D Blaise, A M Stoppa, et al.
Pathologie-Biologie|September 1, 1988
[Prophylaxis of Gram-positive infections after bone marrow graft. Controlled study of the 6-day administration of vancomycin. Intermediate analysis of 60 patients]D Maraninchi, O Hartman, E Benhamou, et al.
Bone Marrow Transplantation|August 1, 1991
Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patientsD Blaise, D Olive, M Hirn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
Patient participation in medical decision-making: a French study in adjuvant radio-chemotherapy for early breast cancerC Protière, P Viens, D Genre, et al.
Bone Marrow Transplantation|November 1, 1994
Delayed administration of granulocyte colony-stimulating factor after autologous bone marrow transplantation: effect on granulocyte recoveryN Vey, S Molnar, C Faucher, et al.
Acta Endocrinologica|July 1, 1993
Incidence rate and risk factors for thyroid dysfunction during recombinant interleukin-2 therapy in advanced malignanciesB Vialettes, M A Guillerand, P Viens, et al.
Pageof 25